Description

YK-11 5mg 90tabs

YK-11 SARM – Myostatin Inhibitor for Advanced Muscle Development

Product Overview

YK-11 is a synthetic steroidal compound classified as a selective androgen receptor modulator (SARM) that has garnered attention in scientific research for its unique dual mechanism of action. Unlike conventional SARMs that function solely through androgen receptor agonism, YK-11 exhibits a distinctive capacity to inhibit myostatin – a protein that naturally restricts muscle growth – while simultaneously activating androgen receptor pathways.

Each bottle contains 90 capsules, with each capsule delivering 5 mg of YK-11. This formulation is designed to provide flexibility for researchers and advanced users seeking precise dosage control. The compound is recognized for its partial androgen receptor agonist activity, which theoretical models suggest may offer a more selective anabolic profile compared to full agonists like testosterone.

Mechanism of Action

YK-11 operates through two complementary pathways. First, it functions as a partial agonist of the androgen receptor (AR), binding to the receptor without inducing the full transcriptional activation seen with endogenous androgens such as dihydrotestosterone (DHT). Second, and perhaps more significantly, YK-11 increases the expression of follistatin, a protein that binds to and inhibits myostatin. Myostatin is a negative regulator of muscle growth, and its inhibition removes a primary biological limitation on muscle development.

This dual mechanism distinguishes YK-11 from both traditional anabolic steroids and other SARM candidates in experimental muscle and bone research applications. Research has also demonstrated that YK-11 promotes osteoblastic proliferation and differentiation, suggesting potential applications in bone health research.

Recommended Usage

Dosage protocols vary based on user experience and research objectives:

• Novice users: 5-10 mg per day

• Intermediate users: 10-15 mg per day

• Advanced researchers: Up to 30 mg per day

Experts recommend splitting the daily dose into two administrations for more stable blood levels and potentially improved results. The 5 mg capsule format allows for precise titration according to individual research requirements.

Common Stacking Protocols

YK-11 is frequently incorporated into comprehensive bulking stacks. Typical combinations include:

• YK-11 with MK-677 and RAD-140

• YK-11 with MK-677 and LGD-4033

• YK-11 with MK-677 and S-4 or S-23

• Optional addition of MK-2866 (Ostarine)

These stacking protocols are designed to synergistically support anabolic signaling pathways and myostatin inhibition for enhanced research outcomes.

Side Effect Profile

Reported adverse effects associated with YK-11 use are relatively limited in available literature. However, emerging research has identified several areas of concern that researchers should consider.

A 2024 study published in Chemico-Biological Interactions demonstrated that YK-11, at anabolic doses, significantly alters hippocampal neurochemistry in animal models, leading to impairments in memory consolidation. The same study identified that YK-11 increases pro-inflammatory cytokines IL-1β and IL-6 while reducing anti-inflammatory IL-10 levels in hippocampal tissue.

Additional research has indicated that YK-11 administration may promote oxidative stress and mitochondrial dysfunction. As with all SARMs, YK-11 may suppress natural testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis.

Users have also reported potential ligament issues, and some researchers recommend concurrent supplementation with collagen and glucosamine during research protocols.

Important Safety Information

YK-11 is an investigational compound that has not been approved by the FDA for human use. It has not completed clinical trials and is not approved for human consumption. Clinical trials and case studies have linked SARMs to severe adverse effects, including liver injury, increased heart attack and stroke risk, and thrombosis.

This product is intended for research purposes only. Always consult a qualified healthcare provider before initiating any research protocol involving investigational compounds.

---

Top 10 Frequently Asked Questions About YK-11

Q1: What is the primary mechanism of action for YK-11?

YK-11 is a synthetic, steroidal selective androgen receptor modulator (SARM) with a unique dual mechanism. It acts as a partial agonist of the androgen receptor and significantly increases follistatin expression, which binds to and inhibits myostatin – a protein that restricts muscle growth.

Q2: Is YK-11 approved for human use?

No. YK-11 is an investigational compound that has not been approved by the FDA or any other regulatory agency for human use. It has not completed clinical trials and is not approved for human consumption.

Q3: What are the known side effects of YK-11?

Reported side effects include testosterone suppression, potential liver enzyme elevation, and androgenic effects such as hair loss. Recent animal studies have also identified impacts on hippocampal function, including oxidative stress, mitochondrial dysfunction, and potential memory consolidation impairment.

Q4: What is the recommended dosage of YK-11?

Dosage recommendations vary: novice users typically take 5-10 mg per day, intermediate users 10-15 mg per day, and advanced researchers may use up to 30 mg per day. Splitting the daily dose is often recommended for better results.

Q5: How does YK-11 differ from other SARMs?

YK-11 is unique among SARMs due to its dual action – it not only binds to androgen receptors but also inhibits myostatin through follistatin upregulation. This distinguishes it from conventional SARMs that rely solely on androgen receptor agonism.

Q6: Can YK-11 affect cognitive function?

Recent research published in Chemico-Biological Interactions (2024) suggests that YK-11, at anabolic doses, significantly alters hippocampal neurochemistry and may lead to impairments in memory consolidation in animal models. The compound has demonstrated high brain permeability in physiologically based pharmacokinetic modeling.

Q7: Does YK-11 suppress natural testosterone production?

Yes. Like other SARMs, YK-11 can suppress natural testosterone production through negative feedback on the hypothalamic-pituitary-gonadal axis. Post-cycle therapy may be necessary to normalize endogenous testosterone production.

Q8: What compounds are commonly stacked with YK-11?

Typical bulking stacks include YK-11 with MK-677 and RAD-140, LGD-4033, S-4, or S-23. MK-2866 (Ostarine) may be added optionally.

Q9: Is YK-11 a steroid or a SARM?

YK-11 occupies a unique position – it is chemically structured as a steroidal compound derived from dihydrotestosterone (DHT) but is marketed and classified as a selective androgen receptor modulator. It is technically both a steroidal compound and a SARM.

Q10: What does the scientific literature say about YK-11’s safety?

Available research raises significant safety concerns. Studies have linked YK-11 to oxidative stress, mitochondrial dysfunction, hippocampal neurotoxicity, and pro-inflammatory effects. The compound has not undergone human clinical trials, and its long-term safety profile remains largely unknown.

---

References and Reputable Sources

• PubMed – YK11 induces oxidative stress and mitochondrial dysfunction in hippocampus

• PubMed – From gains to gaps? How Selective Androgen Receptor Modulator (SARM) YK11 impact hippocampal function

• PubMed – Detection of YK-11 in a doping control sample

• UK Anti-Doping – About SARMs and associated risks

• National Institutes of Health – SARM research publications

---

YK-11 represents one of the most intriguing compounds in the SARM category, offering a unique dual mechanism that sets it apart from conventional options. Whether you are a researcher investigating myostatin inhibition pathways or an advanced user seeking to explore the potential of this compound, quality and purity are paramount.

Visit AnabolicSteroidsOnline.shop today to secure your YK-11 supply. Each bottle contains 90 capsules of precisely dosed 5 mg YK-11, manufactured to the highest standards for research applications. Click here to place your order and advance your research protocols with confidence.